Woojin M. Han

Woojin M. Han

Auto-generated profile, based on publicly available information

Woojin M. Han

Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAmy Y. Clark
Amy Y. Clark
KMKaren E. Martin
Karen E. Martin
JGJosé R. García
José R. García
CJChristopher M Johnson
Christopher M Johnson
HTHannah S. Theriault
Hannah S. Theriault
AGAndres Garcia
Andres Garcia
Stem cell therapies are limited by poor cell survival and engraftment. A hurdle to the use of materials for cell delivery is the lack of understanding of material properties that govern transplanted stem cell functionality. Here, we show that synthetic hydrogels presenting integrin-specific peptides enhance the survival, persistence, and osteo-reparative functions of human bone marrow-derived mesenchymal stem cells (hMSCs) transplanted in murine bone defects. Integrin-specific hydrogels regulate hMSC adhesion, paracrine signaling, and osteoblastic differentiation in vitro. Hydrogels presenting GFOGER, a peptide targeting α2β1 integrin, prolong hMSC survival and engraftment in a segmental bone defect and result in improved bone repair compared to other peptides. Integrin-specific hydrogels have diverse pleiotropic effects on hMSC reparative activities, modulating in vitro cytokine secretion and in vivo gene expression for effectors associated with inflammation, vascularization, and bone formation. These results demonstrate that integrin-specific hydrogels improve tissue healing by directing hMSC survival, engraftment, and reparative activities.

3 August 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
WHWoojin M. Han
Woojin M. Han
SAShannon E. Anderson
Shannon E. Anderson
MMMahir Mohiuddin
Mahir Mohiuddin
DBDaniela Barros
Daniela Barros
SNShadi A. Nakhai
Shadi A. Nakhai
YJYoung Charles Jang
Young Charles Jang
Synthetic designer matrix enhances muscle stem cell function and engraftment in injured dystrophic and aged skeletal muscles.

30 March 2023 in Stem Cell Reports
Verified
Journal Article
Open access
CFChengcheng Fu
Chengcheng Fu
BCBritney Chin-Young
Britney Chin-Young
GPGaYoung Park
GaYoung Park
MGMariana Guzmán-Seda
Mariana Guzmán-Seda
DLDamien Laudier
Damien Laudier
WHWoojin M. Han
Woojin M. Han
Intramuscular fatty infiltration in muscle injuries and diseases, caused by aberrant adipogenesis of fibro-adipogenic progenitors, negatively impacts function. Intramuscular delivery of wingless-type MMTV integration site family 7a (WNT7A) offers a promising strategy to stimulate muscle regeneration, but its effects on adipogenic conversion of fibro-adipogenic progenitors remain unknown. Here, we show that WNT7A decreases adipogenesis of fibro-adipogenic progenitors (FAPs) by inducing nuclear localization of Yes-associated protein (YAP) through Rho in a β-CATENIN-independent manner and by promoting nuclear retention of YAP and transcriptional co-activator with PDZ-binding motif (TAZ) in differentiating FAPs. Furthermore, intramuscular injection of WNT7A in vivo effectively suppresses fatty infiltration in mice following glycerol-induced injury. Our results collectively suggest WNT7A as a potential protein-based therapeutic for diminishing adipogenesis of FAPs and intramuscular fatty infiltration in pathological muscle injuries or diseases.

9 October 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
DBDaniela Barros
Daniela Barros
Eduardo Conde-SousaEduardo Conde-Sousa
Eduardo Conde-Sousa
AGAndreia M. Gonçalves
Andreia M. Gonçalves
WHWoojin M. Han
Woojin M. Han
AGAndres Garcia
Andres Garcia
APAna Paula Pêgo
Ana Paula Pêgo
Laminin incorporation into biological or synthetic hydrogels has been explored to recapitulate the dynamic nature and biological complexity of neural stem cell (NSC) niches. However, the strategies currently explored for laminin immobilization within three-dimensional (3D) matrices do not address a critical aspect influencing cell–matrix interactions, which is the control over laminin conformation and orientation upon immobilization. This is a key feature for the preservation of the protein bioactivity. In this work, we explored an affinity-based approach to mediate the site-selective immobilization of laminin into a degradable synthetic hydrogel. Specifically, a four-arm maleimide terminated poly(ethylene glycol) (PEG-4MAL) macromer was functionalized with a mono-PEGylated recombinant human N-terminal agrin (NtA) domain, to promote high affinity binding of laminin. Different NtA concentrations (10, 50 and 100 μM) were used to investigate the impact of NtA density on laminin incorporation, hydrogel biophysical properties, and biological outcome. Laminin was efficiently incorporated for all the conditions tested (laminin incorporation >95%), and the developed hydrogels revealed mechanical properties (average storage modulus (G′) ranging from 187 to 256 Pa) within the values preferred for NSC proliferation and neurite branching and extension. Affinity-bound laminin PEG-4MAL hydrogels better preserve laminin bioactivity, compared to unmodified hydrogels and hydrogels containing physically entrapped laminin, this effect being dependent on NtA concentration. This was evidenced by the 10 μM NtA-functionalized PEG-4MAL gels incorporating laminin that support enhanced human NSC proliferation and neurite extension, compared to the latter. Overall, this work highlights the potential of the proposed engineered matrices to be used as defined 3D platforms for the establishment of artificial NSC niches and as extracellular matrix-mimetic microenvironments to support human NSC transplantation.

23 September 2021 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
CFChengcheng Fu
Chengcheng Fu
AHAlice H. Huang
Alice H. Huang
LGLeesa M. Galatz
Leesa M. Galatz
WHWoojin M. Han
Woojin M. Han

1 March 2025 in Advances in Wound Care
Verified
Journal Article
Closed access
CCCharlene W. Cai
Charlene W. Cai
JGJosh A. Grey
Josh A. Grey
DHDirk Hubmacher
Dirk Hubmacher
WHWoojin M. Han
Woojin M. Han
Volumetric muscle loss (VML) is caused by the loss of significant amounts of skeletal muscle tissue. VML cannot be repaired by intrinsic regenerative processes, resulting in permanent loss of muscle function and disability. Current rehabilitative-focused treatment strategies lack efficacy and do not restore muscle function, indicating the need for the development of effective regenerative strategies. Recent developments implicate biomaterial-based approaches for promoting muscle repair and functional restoration post-VML. Specifically, bioscaffolds transplanted in the injury site have been utilized to mimic endogenous cues of the ablated tissue to promote myogenic pathways, increase neo-myofiber synthesis, and ultimately, restore contractile function to the injured unit. Despite the development and pre-clinical testing of various biomaterial-based regenerative strategies, effective therapies for patients are not available. The unique challenges posed for biomaterial-based treatments of VML injuries, including its scalability, and clinical applicability beyond small-animal models, impede progress. Furthermore, production of tissue engineered constructs is technically demanding, with reproducibility issues at scale and complexities in achieving vascularization and innervation of large constructs. Biomaterial-based regenerative strategies designed to comprehensively address the pathophysiology of VML are needed. Considerations for clinical translation, including scalability and regulatory compliance, should also be considered when developing such strategies. Additionally, an integrated approach that combines regenerative and rehabilitative strategies is essential for ensuring functional improvement.